NVCT

Nuvectis Pharma, Inc. NASDAQ Listed Feb 4, 2022

Healthcare ·Biotechnology ·US · nuvectis.com

$10.32

Mkt Cap $273.7M

52w Low $5.55 85.2% of range 52w High $11.15

50d MA $8.56 200d MA $7.41

P/E (TTM) -6.5x

EV/EBITDA -4.8x

P/B 10.1x

Debt/Equity 0.0x

ROE -143.6%

P/FCF -10.3x

RSI (14) —

ATR (14) —

Beta -0.21

50d MA $8.56

200d MA $7.41

Avg Volume 58.5K

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.

SIC Code

2834

CIK (SEC)

1875558

Phone

201 614 3150

1 Bridge Plaza · Fort Lee, NJ 07024 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 11, 2026	BMO	-0.26	-0.31	-19.2%	8.78	+0.7%	+0.2%	+0.0%	-0.5%	+1.8%	-3.3%	—
Nov 4, 2025	BMO	-0.24	-0.44	-83.3%	5.88	-0.5%	-3.9%	+0.0%	+0.4%	+8.3%	-1.1%	—
Aug 5, 2025	BMO	-0.25	-0.30	-20.0%	6.90	-1.4%	-6.4%	+0.0%	-4.5%	-2.8%	+2.2%	—
May 6, 2025	BMO	-0.30	-0.27	+10.0%	8.96	+0.7%	-2.2%	+0.0%	+5.3%	-2.5%	-6.7%	—
Feb 25, 2025	BMO	-0.28	-0.36	-28.6%	6.93	+2.9%	-1.0%	+0.0%	-2.2%	-0.3%	-8.2%	—
Nov 5, 2024	BMO	-0.26	-0.24	+7.7%	7.43	-1.9%	+9.7%	+0.0%	+2.3%	+29.6%	+0.0%	—
Aug 6, 2024	BMO	-0.26	-0.26	+0.0%	6.62	-0.3%	+0.3%	+0.0%	+3.0%	-0.9%	-7.1%	—
May 7, 2024	BMO	-0.40	-0.25	+37.5%	7.19	-2.6%	-10.6%	+0.0%	-0.8%	+0.3%	-0.8%	—
Mar 5, 2024	BMO	-0.40	-0.41	-2.5%	10.20	-0.2%	-3.5%	+0.0%	+3.3%	+1.0%	-1.1%	—
Nov 8, 2023	BMO	-0.38	-0.37	+2.6%	8.24	+9.2%	-0.1%	+0.0%	-2.1%	+3.6%	+1.0%	—
Aug 9, 2023	BMO	-0.34	-0.38	-11.8%	14.94	-1.3%	+0.4%	+0.0%	+2.1%	-2.3%	-5.3%	—
May 10, 2023	BMO	-0.44	-0.27	+38.6%	15.13	+0.1%	+0.8%	+0.0%	+4.8%	+6.2%	-0.4%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Aug 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$6.80	$6.80	+0.0%	+7.2%	-5.3%	-6.4%	-4.5%	-2.8%
Apr 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$10.33	$10.30	-0.3%	-3.6%	-3.4%	-3.8%	+1.3%	-4.4%
Feb 25	HC Wainwright & Co.	Maintains	Buy → Buy	—	$7.36	$7.26	-1.4%	-5.8%	-1.0%	-2.2%	-0.3%	-8.2%
Aug 6	HC Wainwright & Co.	Maintains	Buy → Buy	—	$7.03	$7.01	-0.3%	-5.8%	+0.3%	+3.0%	-0.9%	-7.1%
May 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$7.19	$7.00	-2.6%	-10.6%	-0.8%	+0.3%	-0.8%	+6.6%
Sep 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$14.02	$14.07	+0.4%	+4.0%	-0.5%	-1.8%	-4.1%	+0.1%
Mar 7	HC Wainwright & Co.	Maintains	Buy → Buy	—	$11.90	$11.67	-1.9%	-4.7%	-2.5%	-9.6%	+7.7%	-7.7%
Feb 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$11.82	$11.82	+0.0%	+21.6%	-17.5%	-9.7%	-3.3%	-3.5%
Jul 13	Ladenburg Thalmann	Maintains	Buy → Buy	—	$12.69	$12.69	+0.0%	-6.5%	-2.8%	-2.1%	+0.4%	-0.3%
May 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$15.06	$15.06	+0.0%	-5.6%	+11.6%	+12.5%	+5.5%	+0.8%
Mar 2	HC Wainwright & Co.	Maintains	Buy → Buy	—	$6.81	$7.18	+5.4%	-2.9%	+11.5%	+2.2%	+3.3%	+3.5%

Data updated apr 26, 2026 4:14pm · Source: massive.com